Petros Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)
Petros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(6.6%),Daniel B. Asher(6.6%), etc.
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Boctor Fady
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arnold Mitchell
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bradley Greg
Petros Pharmaceuticals | D: Filing D
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bradley Greg
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bradley Greg
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Petros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(7.6%),Daniel B. Asher(7.6%), etc.
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data
No Data